Immunologists Prakash Nagarkatti and Mitzi Nagarkatti of the University of South Carolina explain what makes it different from previous variants, whether there will be another surge in the US and how best to protect yourself.
Prakash Nagarkatti, PhD
Dr. Prakash Nagarkatti currently serves as Vice President for Research (VPR) and Carolina Distinguished Professor at the University of South Carolina (USC). In his role as VPR at USC, he oversees research enterprise of ~$280 million. He currently directs three federally-funded Research Centers. He has published ~300 peer-reviewed papers in the areas of inflammation. For his outstanding contributions to science, Dr. Nagarkatti was elected Fellow of American Association for the Advancement of Science (AAAS), Fellow of Academy of Toxicological Sciences (ATS), and a Fellow of the National Academy of Inventors.